TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25153084

Group type: EXPERIMENTAL
Intervention: Once-daily protease inhibitor (PI) based regimen (ATV+DDI+FTC)
Number of subjects: 1571

Group type: EXPERIMENTAL
Intervention: Once-daily non-nucleoside reverse transcriptase inhibitor/nucleoside reverse transcriptase inhibitor (NNRTI/NRTI) regimen (EFV+FTC/TDF)
Number of subjects: 1571

Group type: COMPARATOR
Intervention: Twice-daily NNRTI/NRTI regimen (EFV+3TC/ZDV)
Number of subjects: 1571

Group type: EXPERIMENTAL
Intervention: Pill-count non-adherence
Number of subjects: 1571

Group type: EXPERIMENTAL
Intervention: Self-report non-adherence
Number of subjects: 1571
Study: 22149319

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 150

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: CYP3A5 *3/*3 variant
Number of subjects: 150
Study: 19319182

Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied to the anterior temporal lobes throughout the encoding and retrieval stages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bilateral stimulation (anodal left/cathodal right anterior temporal lobe stimulation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unilateral stimulation (anodal left ATL stimulation with a large contralateral cathodal electrode)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 17401619

Group type: EXPERIMENTAL
Intervention: IOLMaster measurements
Number of subjects: 95
Study: 15180172

Group type: EXPERIMENTAL
Intervention: Alternative treatment with Otovowen (fixed combination of plant‐based tinctures and homeopathic potencies)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Conventional treatment (free combinations of decongestant nose drops, mucolytics, analgesics and antibiotics)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Alternative treatment with Otovowen
Number of subjects: 390

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 390
Study: 11467436

Group type: EXPERIMENTAL
Intervention: Warm blood cardioplegic induction (group T)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cold blood cardioplegic induction (group C)
Number of subjects: 28
Study: 9570261

Group type: EXPERIMENTAL
Intervention: Omeprazole treatment strategy (10 mg stepping up to 20 mg and 40 mg as required)
Number of subjects: 725

Group type: COMPARATOR
Intervention: Antacid-alginate/ranitidine treatment strategy (10 mL q.d.s. stepping up to ranitidine 150 mg b.d. and 150 mg q.d.s. as required)
Number of subjects: 725
Study: 7774326

Group type: EXPERIMENTAL
Intervention: Folate and vitamin B12
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 38
Study: 3078803

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccines
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 31024112

Group type: EXPERIMENTAL
Intervention: RCTs with funding statements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RCTs with intervention description
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inclusion of IRB statements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blinding and allocation concealment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Jadad scores
Number of subjects: 0
Study: 31246083

Group type: EXPERIMENTAL
Intervention: Decayed, Missing and Filled Teeth (DMFT/dmtf) index
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Dental Aesthetic Index (DAI)
Number of subjects: 530
Study: 28659128

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation plus minimally invasive esophagectomy (MIE)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy plus minimally invasive esophagectomy (MIE)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation plus MIE
Number of subjects: 264

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy plus MIE
Number of subjects: 264
Study: 26125194

Group type: EXPERIMENTAL
Intervention: Continuous fascia iliaca compartment block (FIB)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA) using fentanyl
Number of subjects: 51
Study: 23813280

Group type: EXPERIMENTAL
Intervention: 6-month multimodal training
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 117
Study: 20510611

Group type: EXPERIMENTAL
Intervention: Static air overlay mattress on top of a cold foam mattress
Number of subjects: 83

Group type: COMPARATOR
Intervention: Cold foam mattress alone
Number of subjects: 83
Study: 19016274

Group type: EXPERIMENTAL
Intervention: Division of short gastric vessels (group 1)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Intact short gastric vessels (group 2)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 99
Study: 16771939

Group type: EXPERIMENTAL
Intervention: Intravenous erythromycin (250 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 14607452

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 1041

Group type: COMPARATOR
Intervention: TEE-guided treatment
Number of subjects: 1041

Group type: COMPARATOR
Intervention: No spontaneous conversion (No-SC)
Number of subjects: 1041
Study: 10997674

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parenteral Nutrition (PN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No Parenteral Nutrition (no PN)
Number of subjects: 0
Study: 8737165

Group type: EXPERIMENTAL
Intervention: Water available on the dining table
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water available 20 feet from the table
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water available 40 feet from the table
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing effort to obtain water
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of a social model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social and economic factors interaction
Number of subjects: 0
Study: 1483291

Group type: EXPERIMENTAL
Intervention: Morphine 5 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Naloxone 1.2 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sterile water (Control)
Number of subjects: 28
Study: 2932138

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 80 micrograms
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 200 micrograms
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 400 micrograms
Number of subjects: 9
Study: 30736479

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum PS128 supplementation
Number of subjects: 0
Study: 30290769

Group type: EXPERIMENTAL
Intervention: Antenatal care (ANC) clinic attendance
Number of subjects: 1719

Group type: EXPERIMENTAL
Intervention: HIV status check
Number of subjects: 1719

Group type: EXPERIMENTAL
Intervention: Hemoglobin level check
Number of subjects: 1719

Group type: EXPERIMENTAL
Intervention: Syphilis screening
Number of subjects: 1719

Group type: EXPERIMENTAL
Intervention: Tetanus toxoid vaccination
Number of subjects: 1719

Group type: EXPERIMENTAL
Intervention: Antimalarial drugs
Number of subjects: 1719

Group type: EXPERIMENTAL
Intervention: Antihelminthic drugs
Number of subjects: 1719

Group type: EXPERIMENTAL
Intervention: Iron supplements
Number of subjects: 1719
Study: 27338180

Group type: EXPERIMENTAL
Intervention: Burn cohort
Number of subjects: 30997

Group type: EXPERIMENTAL
Intervention: Burn cohort (children <18 years)
Number of subjects: 30997

Group type: EXPERIMENTAL
Intervention: Burn cohort (adults ≥18 years)
Number of subjects: 30997
Study: 24997307

Group type: EXPERIMENTAL
Intervention: Heavy/continuous smokers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Occasional smokers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quitters/decreasers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 0
Study: 22572911

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 1152
Study: 20683355

Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 18

Group type: COMPARATOR
Intervention: No stretching
Number of subjects: 18
Study: 18727948

Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 16840580

Group type: EXPERIMENTAL
Intervention: CHO+MCFA-rich oil emulsion after the 2-wk MCFA-rich dietary condition (MC-MC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: CHO+MCFA-rich oil emulsion after one of the LCFA-rich dietary conditions (LC-MC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: CHO only following a LCFA-rich diet (LC-CHO)
Number of subjects: 9
Study: 12505955

Group type: EXPERIMENTAL
Intervention: Jet with 0.5 mL of lidocaine 1%
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Jet with 0.5 mL of lidocaine 2%
Number of subjects: 400

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Jet with 0.5 mL of saline
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Jet with lidocaine 1%
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Jet with lidocaine 2%
Number of subjects: 400
Study: 11783225

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Amino acid (Control)
Number of subjects: 55
Study: 7751490

Group type: EXPERIMENTAL
Intervention: Social support treatment
Number of subjects: 137

Group type: COMPARATOR
Intervention: Self-control treatment
Number of subjects: 137
Study: 10171156

Group type: EXPERIMENTAL
Intervention: Biomedicus vortex pump (Group B)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Stockert roller pump (Group S)
Number of subjects: 16
Study: 367884

Group type: EXPERIMENTAL
Intervention: Intravenous diazepam 20 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Intravenous diazepam 5 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Intravenous diazepam 10 mg
Number of subjects: 18
Study: 31889322

Group type: EXPERIMENTAL
Intervention: Sofosbuvir plus daclatasvir (Gp 1)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Ombitasvir, paritaprevir and ritonavir plus ribavirin (Gp 2)
Number of subjects: 107
Study: 31152588

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29086025

Group type: EXPERIMENTAL
Intervention: Capsulotomy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-capsulotomy (Control)
Number of subjects: 64
Study: 25972490

Group type: EXPERIMENTAL
Intervention: THC 1.5 mg three times daily for 3 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo three times daily for 3 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: THC 1.5 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 23279569

Group type: EXPERIMENTAL
Intervention: Active anodal tDCS of the right primary motor cortex (M1)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Active anodal tDCS of the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 18
Study: 21675867

Group type: EXPERIMENTAL
Intervention: Nonmydriatic retinal imaging and discussion of retinal findings
Number of subjects: 113

Group type: COMPARATOR
Intervention: Standard endocrinology evaluation alone
Number of subjects: 113
Study: 18264836

Group type: EXPERIMENTAL
Intervention: Abdominal liposuction (AL)
Number of subjects: 20
Study: 16408462

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antihyperglycemic agent treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 12570112

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (Symbicort) 160/4.5 microg
Number of subjects: 812

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 812

Group type: COMPARATOR
Intervention: Formoterol 4.5 microg
Number of subjects: 812

Group type: COMPARATOR
Intervention: Budesonide 200 microg
Number of subjects: 812
Study: 12690774

Group type: EXPERIMENTAL
Intervention: Instructions designed by the researcher plus routine hospital instructions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine hospital instructions only
Number of subjects: 60
Study: 9739438

Group type: EXPERIMENTAL
Intervention: 5‐FU 425 mg/m2 given by bolus injection on days 1‐5 plus intravenous (i.v.) LV 20 mg/m2 every four to five weeks
Number of subjects: 306

Group type: COMPARATOR
Intervention: 5‐FU 3.5 g/m2/week in a 48‐hour continuous infusion
Number of subjects: 306
Study: 7994260

Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) administration during and after autologous bone marrow transplantation (BMT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Busulfan and cyclophosphamide conditioning regimen prior to BMT
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cultured marrow cells infused on day 0 after 8 days of culture with IL-2
Number of subjects: 10
Study: 2920496

Group type: EXPERIMENTAL
Intervention: Levodopa (250 mg) with Ferrous sulfate (325 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Levodopa (250 mg) without Ferrous sulfate (325 mg)
Number of subjects: 8
Study: 7402678

Group type: EXPERIMENTAL
Intervention: Warning signal before noxious stimuli (45-51°C)
Number of subjects: 7

Group type: COMPARATOR
Intervention: No warning signal before noxious stimuli (45-51°C)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Affect-result responses
Number of subjects: 7

Group type: COMPARATOR
Intervention: Affect-process responses
Number of subjects: 7
Study: 31103505

Group type: EXPERIMENTAL
Intervention: Hand Massage
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hand Holding
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 60
Study: 29459019

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (rtCGM)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (self-monitoring of blood glucose)
Number of subjects: 149
Study: 27697278

Group type: EXPERIMENTAL
Intervention: Triple P: Positive Parenting Program (8 weeks of group online participation)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 12
Study: 25065293

Group type: EXPERIMENTAL
Intervention: FEC-D chemotherapy
Number of subjects: 830

Group type: COMPARATOR
Intervention: Standard anthracycline-based chemotherapy
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 830
Study: 23229693

Group type: EXPERIMENTAL
Intervention: Immediate office-based nasolacrimal duct probing
Number of subjects: 163

Group type: COMPARATOR
Intervention: Observation/nonsurgical management followed by deferred facility probing
Number of subjects: 163
Study: 18692279

Group type: EXPERIMENTAL
Intervention: Enhanced model of clinical placement for final year nursing students (trial participants)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Non-trial participants (control group)
Number of subjects: 92
Study: 17990386

Group type: EXPERIMENTAL
Intervention: Automated percutaneous discectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser discectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiofrequency denervation
Number of subjects: 0
Study: 15724823

Group type: EXPERIMENTAL
Intervention: Music listening (experimental group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-listening (control group)
Number of subjects: 0
Study: 16579083

Group type: EXPERIMENTAL
Intervention: No. 2 Qu Feng Shi Ling capsules and Fenbid
Number of subjects: 82

Group type: COMPARATOR
Intervention: Lei Gong Teng Tablets and Fenbid
Number of subjects: 82
Study: 9534837

Group type: EXPERIMENTAL
Intervention: Educational intervention about tardive dyskinesia
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 56
Study: 7655378

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (4800-6000 mg/m2) and carboplatin (1200-1800 mg/m2) followed by autologous bone marrow or peripheral blood stem cell infusion
Number of subjects: 43

Group type: COMPARATOR
Intervention: High-dose cyclophosphamide and carboplatin regimen
Number of subjects: 43
Study: 2541168

Group type: EXPERIMENTAL
Intervention: 10(4) PFU of D x RRV reassortant
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 10(4) PFU of DS1 x RRV reassortant
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 10(4) PFU of RRV
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 5 x 10(3) PFU of D x RRV and 5 x 10(3) PFU of RRV
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 1213

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 58

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 58
Study: 31582408

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (ILS)
Number of subjects: 2015

Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 2015

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 2015
Study: 26727045

Group type: EXPERIMENTAL
Intervention: RFCA
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: CRYO
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: COMBINED
Number of subjects: 237
Study: 23564922

Group type: EXPERIMENTAL
Intervention: Glucagon-like peptide 1 (GLP-1) infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acute hyperglycemia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acute hypoglycemia
Number of subjects: 0
Study: 21864370

Group type: EXPERIMENTAL
Intervention: PEPS therapy plus treatment as usual (TAU)
Number of subjects: 340

Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: PEPS therapy plus TAU
Number of subjects: 340
Study: 20046538

Group type: EXPERIMENTAL
Intervention: Screening, brief intervention and referral to treatment (SBIRT)
Number of subjects: 0
Study: 17084787

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive‐Behavioral Coping Skills Therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Twelve‐Step Facilitation Therapy
Number of subjects: 0
Study: 15605326

Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation and Prevention Program (CRPP) - an 8-week exercise and education class in phase 2
Number of subjects: 269

Group type: COMPARATOR
Intervention: Conventional therapy without exercise program (control group)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Cost utility of CRPP
Number of subjects: 269
Study: 11287029

Group type: EXPERIMENTAL
Intervention: DMPA+E(2)C injection on day 7 of the menstrual cycle (delayed-injection group, n = 117)
Number of subjects: 158

Group type: COMPARATOR
Intervention: DMPA+E(2)C injection on day 5 of the menstrual cycle (control group, n = 41)
Number of subjects: 158
Study: 9311402

Group type: EXPERIMENTAL
Intervention: Hypnosis (audio tape daily 4-6 days prior to surgery)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no hypnosis)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study: 8455803

Group type: EXPERIMENTAL
Intervention: Marine fish-oil supplements rich in n-3 fatty acids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marine fish-oil supplements
Number of subjects: 0
Study: 3510017

Group type: EXPERIMENTAL
Intervention: Nurse home visitation during pregnancy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (no nurse home visitation)
Number of subjects: 0
Study: 31738792

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (20 sessions over 10 weeks) targeting gait and balance, delivered by physiotherapists.
Number of subjects: 223
Study: 28461168

Group type: EXPERIMENTAL
Intervention: Advanced communication skills training
Number of subjects: 27425

Group type: COMPARATOR
Intervention: Untrained sites
Number of subjects: 27425
Study: 25739829

Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m²/week for 4 weeks) with glucocorticoids and two intravenous cyclophosphamide pulses
Number of subjects: 44

Group type: COMPARATOR
Intervention: Intravenous cyclophosphamide for 3-6 months followed by azathioprine with glucocorticoids (Control group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Rituximab group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 22706617

Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal patch (5 μg/h)
Number of subjects: 37
Study: 22167031

Group type: EXPERIMENTAL
Intervention: Oral ketamine (10 mg in 20 ml of fruit juice)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (20 ml of fruit juice)
Number of subjects: 36
Study: 18379339

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 25
Study: 17000358

Group type: EXPERIMENTAL
Intervention: Myocardial contrast echocardiography (MCE)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Technetium‐99m sestamibi single photon emission computed tomography (SPECT)‐myocardial perfusion imaging (MPI)
Number of subjects: 51
Study: 12855084

Group type: EXPERIMENTAL
Intervention: Immersive virtual reality (IVR) sessions of V-Store
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-immersive (flat screen) sessions of V-Store
Number of subjects: 0
Study: 11059522

Group type: EXPERIMENTAL
Intervention: Buteyko Breathing Technique (BBT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo video
Number of subjects: 36
Study: 10901839

Group type: EXPERIMENTAL
Intervention: Clobazam (30 mg daily)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Lorazepam (3 mg daily)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Buspirone (30 mg daily)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo (after abrupt withdrawal of clobazam, lorazepam, or buspirone)
Number of subjects: 128
Study: 1511768

Group type: EXPERIMENTAL
Intervention: Newly constructed information leaflet
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Counselling interview
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Medical intervention (colposcopy examination or outpatient ablative treatment)
Number of subjects: 144